Mycophenolate-Induced Hepatotoxicity Precipitates Tacrolimus Nephrotoxicity in a Kidney Transplant Recipient: A Case Report
Authors:
- 9 November 2022
- journal article
- case report
- Published by Elsevier in Transplantation Proceedings
- Vol. 54 (10) , 2739-2743
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tacrolimus therapy causes hepatotoxicity in patients with a history of liver diseaseInt. Journal of Clinical Pharmacology and Therapeutics, 2015
- Liver disease in kidney transplant recipientsTransplantation Reviews, 2015
- Hepatitis Due to Mycophenolate Mofetil Used to Treat Atopic Dermatitis and Allergic Contact DermatitisDermatitis®, 2014
- Acute hepatitis following mycophenolate mofetil administration for ANCA‐positive vasculitisScandinavian Journal of Rheumatology, 2007
- Mycophenolate Sodium-induced Hepatotoxicity: First ReportTransplantation, 2006
- Immunosuppression: Evolution in Practice and Trends, 1994–2004American Journal of Transplantation, 2006
- Liver Enzyme Abnormalities in Patients With Atopic Dermatitis Treated With Mycophenolate MofetilArchives of Dermatology, 2006
- Uncommon Side Effect of MMF in Renal Transplant RecipientsRenal Failure, 2005
- Mycophenolates in transplantationClinical Transplantation, 2004
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990